BPS Bioscience, Inc. Announces 3 New Assay Kits for Bromodomain Screening & Profiling

Expanding the Largest Portfolio of Bromodomain Proteins and Assay Kits for a New Class of Epigenetic Drug Targets
 
SAN DIEGO - March 13, 2013 - PRLog -- BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new  assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs).   These unique assays will also be available for custom services as part of BPS Bioscience’s comprehensive panel of 19 different bromodomains.

Acetylation of lysine residues is a dynamic process that directs gene transcription and chromatin structure.  BRD-containing proteins recognize and bind to these acetylated lysines to regulate epigenetically controlled processes.  Emerging as a promising new class of targets, BRDs, alongside histone deacetylases (HDACs), acetyltransferases (HATs), methyltransferases (HMTs) and demethylases (HDMs) are important in cancer drug discovery and new treatments for diabetes, neurological disorders, and inflammatory diseases.

“These new kits are the latest tools from BPS to support bromodomain drug discovery.” said Suzan Oberle, Senior Director of Sales and Marketing.   "In addition to 14 different BRD kits, BPS’s product portfolio includes over 50 proteins containing one or more bromodomains.  We offer the most extensive BRD product offering anywhere, and we continue to develop new assays, services, and other specialized solutions to help researchers drive lead compounds through their development pipelines.”

BPS is the first company to offer commercially available assay kits for the BRD9, CREBBP and TRIM24 bromodomains. BPS Bioscience aims to make their entire portfolio of high quality bromodomain proteins, assay kits and (+)-JQ1 bromodomain inhibitor easily accessible to all life scientists worldwide.   BPS Bioscience plans to release additional bromodomain proteins and assays in the coming months.

To learn more about BPS Bioscience’s BRD screening/profiling services please visit http://bpsbioscience.com/images/pdf/Bromodomain_services.pdf , and to learn more about all the bromodomain products BPS offers please visit http://bpsbioscience.com/bromodomain.

About BPS Bioscience

BPS Bioscience, Inc. is a leading manufacturer of Bromodomains, Cytokines, HATs, HDACs, HDMs, HMTs, Kinases, Methyl-Lysine Readers, Phosphatases, Phosphodiesterases, Poly ADP Ribose Polymerases (PARPs), Proteases, and Ubiquitin Enzymes.  BPS offers one of the largest selections of recombinant enzymes and assay kits for drug discovery and continues to expand its portfolio of innovative drug discovery products.  BPS also provides custom protein expression, biochemical and cell-based assays, and compound screening and profiling services.  Headquartered in San Diego, California, BPS has provided products and services to pharmaceutical companies and academic institutes in over 45 countries worldwide.  By being at the forefront of technology development, BPS focuses on providing quality life science products and services in a timely manner that will help our customers to accelerate drug discovery and development for treatment of human diseases.  Visit BPS’s website for more information: http://www.bpsbioscience.com.
End
Source: » Follow
Email:***@bpsbioscience.com Email Verified
Tags:Brd, Bromodomain, JQ1, Epigenetics
Industry:Biotech, Research
Location:San Diego - California - United States
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
BPS Bioscience, Inc. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share